文献速递药物不良反应与药物警戒

人工智能时代的患者保护:药物警戒伦理的前沿议题

Safeguarding Patients in the AI Era: Ethics at the Forefront of Pharmacovigilance.
PubMed 文献 · Drug Saf · 2024-09-27

本文探讨人工智能在药物警戒中引发的公平性、非歧视、合规与责任等伦理问题,提出从数据收集、隐私保护、透明度与问责、模型训练及可解释性等方面应对挑战的路线图,并指出透明度、问责、数据保护和公平性是核心需求,强调需协作构建将伦理人工智能整合入药物警戒的认知框架。

要点

  • 人工智能用于药物警戒需关注公平性、非歧视、合规与责任等核心伦理原则
  • 应对挑战需从数据收集、隐私保护、透明度与问责、模型训练和可解释性入手
  • 透明度、问责、数据保护和公平性是当前主要需求,需多方协作构建伦理框架

核心结论

  • 人工智能在药物警戒中的应用需平衡创新与伦理责任,以提升公共卫生结局和患者安全。

主要发现

  • 人工智能在药物警戒中的使用引发了公平性、非歧视、合规和责任等伦理关切。
  • 论文识别了若干负责任的方法,包括伦理框架和最佳实践,以促进人工智能在医疗保健中的使用。
  • 论文认可了一些已证明伦理在人工智能药物警戒中重要性的倡议。

临床怎么用

  • 在药物安全监测中应用人工智能决策时,应考虑数据收集、隐私保护、透明度与问责、模型训练和可解释性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Artificial intelligence is increasingly being used in pharmacovigilance. However, the use of artificial intelligence in pharmacovigilance raises ethical concerns related to fairness, non-discrimination, compliance, and responsibility as the central ethical principles in risk assessment and regulatory requirements. This paper explores these concerns and provides a roadmap to how to address these challenges by considering data collection, privacy protection, transparency and accountability, model training, and explainability in artificial intelligence decision making for drug safety surveillance. A number of responsible approaches have been identified including an ethics framework and best practices to enhance artificial intelligence use in healthcare. The document also recognizes some initiatives that have demonstrated the importance of ethics in artificial intelligence pharmacovigilance. Nevertheless, the major needs mentioned in this paper are transparency, accountability, data protection, and fairness, which stress the necessity of collaboration to construct a cognitive framework aimed at integrating ethical artificial intelligence into pharmacovigilance. In conclusion, innovation should be balanced with ethical responsibility to enhance public health outcomes as well as patient safety.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Jain A, Salas M, Aimer O, et al. Safeguarding Patients in the AI Era: Ethics at the Forefront of Pharmacovigilance. Drug Saf. 2024. PMID: 39331228. doi:10.1007/s40264-024-01483-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。